Fehmi Tabak

Fehmi Tabak

İstanbul University Cerrahpaşa - İstanbul / Türkiye
Medical and Health Sciences / Infectious Diseases
AD Scientific Index ID: 4302447
İstanbul Üniversitesi Cerrahpaşa
person_outline Fehmi Tabak's MOST POPULAR ARTICLES
1-) Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment Clinical rheumatology 39 (7), 2085-2094, 2020
2-) Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon α-2b Gastroenterology 135 (2), 459-467, 2008
3-) Combination of tenofovir disoproxil fumarate and peginterferon α-2a increases loss of hepatitis B surface antigen in patients with chronic hepatitis B Gastroenterology 150 (1), 134-144. e10, 2016
4-) Late HDV RNA relapse after peginterferon alpha‐based therapy of chronic hepatitis delta Hepatology 60 (1), 87-97, 2014
5-) Early on‐treatment prediction of response to peginterferon alfa‐2a for HBeAg‐negative chronic hepatitis B using HBsAg and HBV DNA levels Hepatology 52 (2), 454-461, 2010